ENDRA Life Sciences (NDRA) Reports In-Line Q1 EPS
ENDRA Life Sciences (NASDAQ: NDRA) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07).
For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.
ENDRA Life Sciences (NASDAQ: NDRA) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07).
For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.